New treatment, screening tools could help increase survival rates in pancreatic cancer

Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
As a healthcare worker, Sarah Taylor was familiar with pancreatic cancer before her father was diagnosed about a year and a half ago.
“I panicked because I knew what it meant,” she said.
Less than two months later, her father, Bernie Aldrich, died from the disease. Even with Taylor’s experience in healthcare, the loss was shocking. Her father had seemed “the epitome of health” before going to the doctor with some abdominal pain and receiving his diagnosis.
Many stories of pancreatic cancer patients and loved ones follow a familiar pattern: doctors frequently don’t catch the disease until it has spread. At that point, it’s harder to fight. The lack of early detection is a major reason why pancreatic cancer has one of the lowest survival rates of any cancer.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.
Of the nearly 67,000 people in the U.S. are diagnosed with the disease each year, only about 13 percent survive five years after diagnosis, on average. But recent developments in treatment and detection could help more people with pancreatic cancer survive longer.
Early detection
The pancreas is a small but important gland the helps the body digest food and regulates blood sugar. Unlike some other parts of the body, like the lungs, it doesn’t give tell-tale signals of cancerous growth.
Dr. Mark Truty, a cancer surgeon with Mayo Clinic who specializes in pancreatic cancer, said common symptoms are pain, or weight loss, which could be caused by any number of changes in the body. More specific signs are new diabetes diagnoses, or diabetes getting more difficult to manage.
“By the time symptoms develop,” he said, “it’s already progressed in the majority of patients.”
Truty said he’s seen patients who had CT scans for abdominal pain years before their cancer diagnosis. The scans came up empty. But when Truty and his colleagues went back to some of those scans using AI, they found tumors.
“The AI can actually look at individual pixels,” he said.
Mayo Clinic turned that research into a clinical trial for people with higher risk of pancreatic cancer. It uses AI to search their CT scans for cancer when its small and easier to treat.
Newly approved drug
Dr. Truty said about a decade ago, doctors found a better way to treat pancreatic cancer by combining multiple chemotherapies. Surgeons also have tools to do more complex operations than they could in the past.
These developments have helped to double survival rates in what he calls “the least survivable of all known cancers.” He hopes more advances will double survival rates again in much less time.
A more recent breakthrough has come in the form of a pill the Food and Drug Administration approved this year. Rasonque is the brand name for daraxonrasib. It targets a mutation that helps pancreatic cancers to spread.
Bob Myers has been fighting his own cancer for three years. He just started the new drug about a month ago and said so far it appears to be shrinking his tumors and stopping the mutation. The drug is so new that he’s not sure how long it could help extend his life.
“There's a lot of ups and downs when you have a disease like this. I'm fortunate to be here almost three years now, and I'm counting on being here for longer,” he said.
Taylor, whose dad died of the disease, got involved with the Minnesota chapter of the Pancreatic Cancer Action Network to help raise money and awareness. She is happy to see the new drug added to the list of treatment options and hopes to see more breakthroughs, even though they can’t help her father.
Similarly, Kym Jolstead has continued to raise funds for pancreatic cancer research since losing her mom to the disease in 2021. She launched a line of coffee beans, Kathie’s Coffee, named after her mother, and gives a portion of the money from each bag to the Pancreatic Cancer Action Network.
“I knew that my mom wouldn’t benefit from it,” she said. “But I know that one day it will make a difference.”
